Mathematical modelers have given little attention to the question of how pre-exposure prophylaxis (PrEP) may impact on a generalized national HIV epidemic and its cost-effectiveness, in the context of control strategies such as condom use promotion and expanding ART programs.We use an age- and gender-structured model of the generalized HIV epidemic in South Africa to investigate the potential impact of PrEP in averting new infections. The model utilizes age-structured mortality, fertility, partnership and condom use data to model the spread of HIV and the shift of peak prevalence to older age groups. The model shows that universal PrEP coverage would have to be impractically high to have a significant effect on incidence reduction while ART...
<div><p>Background</p><p>Cost-effectiveness studies inform resource allocation, strategy, and policy...
BackgroundApproaches that allow easy access to pre-exposure prophylaxis (PrEP), such as over-the-cou...
Oral preexposure prophylaxis (PrEP) in the form of tenofovir-disoproxil-fumarate/emtricitabine is be...
Mathematical modelers have given little attention to the question of how pre-exposure prophylaxis (P...
Background: Mathematical modelers have given little attention to the question of how pre-exposure pr...
Background: Mathematical modelers have given little attention to the question of how pre-exposure pr...
Background: Mathematical modelers have given little attention to the question of how pre-exposure pr...
The original publication is available at http:/www.plosone.orgBackground: Mathematical modelers have...
Introduction Although pre-exposure prophylaxis (PrEP.) is an efficacious HIV prevention strategy, it...
Introduction Although pre-exposure prophylaxis (PrEP.) is an efficacious HIV prevention strategy, it...
Introduction Although pre-exposure prophylaxis (PrEP.) is an efficacious HIV prevention strategy, it...
Introduction Although pre-exposure prophylaxis (PrEP.) is an efficacious HIV prevention strategy, it...
Cost-effectiveness studies inform resource allocation, strategy, and policy development. However, du...
BackgroundApproaches that allow easy access to pre-exposure prophylaxis (PrEP), such as over-the-cou...
OBJECTIVES: New HIV infections remain higher in women than men in sub-Saharan Africa. Preexposure pr...
<div><p>Background</p><p>Cost-effectiveness studies inform resource allocation, strategy, and policy...
BackgroundApproaches that allow easy access to pre-exposure prophylaxis (PrEP), such as over-the-cou...
Oral preexposure prophylaxis (PrEP) in the form of tenofovir-disoproxil-fumarate/emtricitabine is be...
Mathematical modelers have given little attention to the question of how pre-exposure prophylaxis (P...
Background: Mathematical modelers have given little attention to the question of how pre-exposure pr...
Background: Mathematical modelers have given little attention to the question of how pre-exposure pr...
Background: Mathematical modelers have given little attention to the question of how pre-exposure pr...
The original publication is available at http:/www.plosone.orgBackground: Mathematical modelers have...
Introduction Although pre-exposure prophylaxis (PrEP.) is an efficacious HIV prevention strategy, it...
Introduction Although pre-exposure prophylaxis (PrEP.) is an efficacious HIV prevention strategy, it...
Introduction Although pre-exposure prophylaxis (PrEP.) is an efficacious HIV prevention strategy, it...
Introduction Although pre-exposure prophylaxis (PrEP.) is an efficacious HIV prevention strategy, it...
Cost-effectiveness studies inform resource allocation, strategy, and policy development. However, du...
BackgroundApproaches that allow easy access to pre-exposure prophylaxis (PrEP), such as over-the-cou...
OBJECTIVES: New HIV infections remain higher in women than men in sub-Saharan Africa. Preexposure pr...
<div><p>Background</p><p>Cost-effectiveness studies inform resource allocation, strategy, and policy...
BackgroundApproaches that allow easy access to pre-exposure prophylaxis (PrEP), such as over-the-cou...
Oral preexposure prophylaxis (PrEP) in the form of tenofovir-disoproxil-fumarate/emtricitabine is be...